Moderna, Inc. (MRNA) Ownership
MRNA ownership summary
as of October 18, 2026- Institutions
- 80.6% of shares outstanding
- Insiders
- 7.34% of shares outstanding
- Shares outstanding
- 399.2M
- Float
- 372.1M shares available to trade
- Short interest
- 9.44% 30.9M shares short
- Days to cover
- 2.00 short interest down 6.1% vs prior month
- Institutions 80.56%
- Insiders 7.34%
- Other investors 12.10%
MRNA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | FMR Inc | 12.99% | 51.9M | $11.31B | +6.2M (+13.5%) | June 30, 2026 |
| 2 | BlackRock Inc | 7.66% | 30.6M | $6.67B | +963,533 (+3.3%) | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 5.81% | 23.2M | $5.06B | +336,334 (+1.5%) | June 30, 2026 |
| 4 | Capital World Investors | 5.58% | 22.3M | $4.86B | +3.6M (+19.1%) | June 30, 2026 |
| 5 | Baillie Gifford & Co Limited. | 4.56% | 18.2M | $3.97B | −1.8M (−8.9%) | June 30, 2026 |
| 6 | State Street Corp | 3.94% | 15.7M | $3.43B | +864,784 (+5.8%) | June 30, 2026 |
| 7 | Vanguard Portfolio Management, LLC | 3.90% | 15.6M | $3.40B | −35,054 (−0.2%) | June 30, 2026 |
| 8 | Geode Capital Management, LLC | 2.43% | 9.7M | $2.12B | +275,203 (+2.9%) | June 30, 2026 |
| 9 | Morgan Stanley - Brokerage Accounts | 2.39% | 9.5M | $2.08B | +1.1M (+12.6%) | June 30, 2026 |
| 10 | Theleme Partners LLP | 2.02% | 8.1M | $1.76B | +9,326 (+0.1%) | June 30, 2026 |
| 11 | Two Sigma Investments LLC | 1.80% | 7.2M | $1.57B | −1.9M (−20.8%) | June 30, 2026 |
| 12 | Amvescap Plc. | 1.45% | 5.8M | $1.26B | +995,541 (+20.8%) | June 30, 2026 |
| 13 | T. Rowe Price Associates, Inc. | 1.40% | 5.6M | $1.22B | +4.9M (+656.8%) | June 30, 2026 |
| 14 | Charles Schwab Investment Management Inc | 1.21% | 4.8M | $1.05B | +104,528 (+2.2%) | June 30, 2026 |
| 15 | The Goldman Sachs Group Inc | 1.17% | 4.7M | $1.02B | −1.9M (−29.3%) | June 30, 2026 |
| 16 | Flagship Ventures Management, Inc. | 1.16% | 4.6M | $1.01B | — | June 30, 2026 |
| 17 | UBS Group AG | 1.12% | 4.5M | $973.0M | +55,304 (+1.3%) | June 30, 2026 |
| 18 | BNP Paribas Arbitrage, SA | 1.10% | 4.4M | $954.3M | +59,901 (+1.4%) | June 30, 2026 |
| 19 | NORGES BANK | 0.76% | 3.0M | $659.7M | +323,242 (+12.0%) | June 30, 2026 |
| 20 | Northern Trust Corp | 0.75% | 3.0M | $650.8M | +33,288 (+1.1%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 15 holders added 19.7M shares and 4 cut 5.6M.
MRNA top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | American Funds Growth Fd of Amer A | 3.75% | 15.0M | $3.27B | — | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 2.84% | 11.4M | $2.48B | −13,010 (−0.1%) | August 31, 2026 |
| 3 | Vanguard 500 Index Investor | 2.44% | 9.8M | $2.13B | +370,287 (+3.9%) | September 30, 2026 |
| 4 | Fidelity Growth Company Fund | 2.06% | 8.2M | $1.80B | +1.4M (+21.3%) | August 31, 2026 |
| 5 | Scottish Mortgage Ord | 1.85% | 7.4M | $1.61B | −468,307 (−6.0%) | July 31, 2026 |
| 6 | Fidelity OTC | 1.30% | 5.2M | $1.13B | −123,200 (−2.3%) | August 31, 2026 |
| 7 | iShares Core S&P 500 ETF | 1.24% | 4.9M | $1.08B | −7,955 (−0.2%) | September 30, 2026 |
| 8 | American Funds IS® Growth 1 | 1.20% | 4.8M | $1.04B | +159,395 (+3.4%) | September 30, 2026 |
| 9 | Fidelity 500 Index | 1.15% | 4.6M | $999.4M | +17,604 (+0.4%) | August 31, 2026 |
| 10 | State Street® SPDR® S&P 500® ETF | 1.14% | 4.6M | $993.3M | — | September 30, 2026 |
| 11 | Vanguard International Growth Inv | 1.12% | 4.5M | $973.9M | −1.4M (−24.1%) | June 30, 2026 |
| 12 | Fidelity Contrafund | 1.08% | 4.3M | $944.1M | −1,452 (−0.0%) | August 31, 2026 |
| 13 | Vanguard Small Cap Index | 1.01% | 4.0M | $881.6M | −4.2M (−50.8%) | September 30, 2026 |
| 14 | Vanguard MStar Mid Cap Index Instl | 0.96% | 3.8M | $838.7M | +3.8M (0.0%) | September 30, 2026 |
| 15 | iShares Biotechnology ETF | 0.71% | 2.9M | $621.3M | −21,592 (−0.8%) | September 30, 2026 |
| 16 | State Street®HlthCrSelSectSPDR®ETF | 0.66% | 2.6M | $574.0M | +8,192 (+0.3%) | September 30, 2026 |
| 17 | Vanguard MStar Small Cap Value Index | 0.66% | 2.6M | $573.8M | −2.6M (−49.6%) | September 30, 2026 |
| 18 | Vanguard US Growth Investor | 0.64% | 2.6M | $555.9M | — | June 30, 2026 |
| 19 | Fidelity Growth Company K6 | 0.59% | 2.4M | $516.7M | +395,800 (+20.0%) | August 31, 2026 |
| 20 | Capital Group Growth ETF | 0.59% | 2.4M | $512.8M | +6,192 (+0.3%) | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
MRNA insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-23 | Stephen Hoge | Sell | $48.84 | 160,009 | $7.8M |
| 2026-01-23 | Ro Khanna | Buy | $48.78 | — | — |
| 2025-12-11 | Noubar Afeyan | Sell | $29.48 | 23,853 | $703,186 |
| 2025-12-09 | Abbas Hussain | Sell | $27.60 | 504 | $13,910 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
MRNA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns MRNA
Institutional investors own 80.6% of Moderna's shares and insiders 7.34%. The largest holder is FMR Inc with 12.99% of the shares (51.9M), as of June 30, 2026. Among the top 20 institutions, 15 added shares and 4 reduced their stake in the latest filings. Short interest is 9.44% of the float, or 2.00 days of average trading volume. The share count rose 542.6% since 2016.
Related: MRNA analyst forecast, MRNA key metrics. See the MRNA stock overview for the latest quote and news.
MRNA ownership FAQ
Who owns the most Moderna stock?
The largest shareholders of Moderna are FMR Inc (12.99%), BlackRock Inc (7.66%), Vanguard Capital Management, LLC (5.81%), Capital World Investors (5.58%), Baillie Gifford & Co Limited. (4.56%).
What percentage of Moderna is owned by institutions?
Institutions hold 80.6% of Moderna's shares outstanding; insiders hold 7.34%.
Which funds own Moderna?
The largest fund holders of Moderna are American Funds Growth Fd of Amer A (3.75%), Vanguard MStar Total Stk Mkt Idx Invest (2.84%), Vanguard 500 Index Investor (2.44%), Fidelity Growth Company Fund (2.06%), Scottish Mortgage Ord (1.85%).
What is Moderna's short interest?
30.9M shares of Moderna were sold short, 9.44% of the float; at the average daily volume it would take 2.00 days to cover.
Are insiders buying or selling Moderna?
Of the latest 4 reported insider transactions in Moderna (since December 9, 2025), 1 were purchases and 3 were sales.
How many shares of Moderna are outstanding?
Moderna has 399.2M shares outstanding, of which 372.1M are in the public float.